The emerging role of the physician in genetic counselling and testing eor heritable breast, ovarian and colon cancer

CMAJ. Canadian Medical Association Journal

Volumn 154, Issue 8, 1996, Pages 1155-1158

  Taylor, Kathryn M ^a   Kelner, Merrijoy J ^b  

^a YORK UNIVERSITY   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BREAST CANCER; CANCER RISK; COLON CANCER; FAMILIAL CANCER; GENETIC COUNSELING; GENETIC SUSCEPTIBILITY; HUMAN; OVARY CANCER; PHYSICIAN ATTITUDE; SHORT SURVEY;

EID: 0029949281     PISSN: 08203946     EISSN: 14882329     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. National Advisory Council tor Human Genome Research: Statement on use of DNA testing for presymptomatic identification of cancer risk. JAMA 1994; 271: 785
2. Cole DEC, Gallinger S, McCready DR et al: Genetic counselling and testing for susceptibility to breast, ovarian and colon cancer Where are we today? Can Med Assoc J 1996; 154: 149-155
3. King MC, Rowell S, Love SM: Inherited breast and ovarian cancer: What are the risks? What are the choices? JAMA 1993; 269: 1975-1980
4. Whittaker LA. The implications ot the Human Genome Project for family practice. J Fam Pract 1992; 35: 294-301
5. Sandler RS, Holland KL, Brooks E et al. Physicians' opinions and use of colorectal cancer screening procedures. N C Med J 1989; 50: 452-455
6. Lippman A: Led (astray) by genetic maps: the cartography of the human genome and health care. Soc Sci Med 1992; 35: 1469-1476
7. Breo DL: Altered fates: counselling families with inherited breast cancer. JAMA 1993; 269: 2017-2022
8. Hubbard R, Wald E: Exploding the Gene Myth, Beacon Press, Boston, 1993
9. Garver KL, Garver B: Eugenics: past, present, and the future. Am J Hum Grnet 1991; 49: 1109-1118
10. Markel H: The stigma of disease: implications of genetic screening. Am J Med 1992; 93: 209-215
11. Papp L: Health Canada to investigate U.S. retailing of genetic testing. Toronto Star 1996; Mar 2: L7
12. Spodick DH: Randomized controlled clinical trials: the behavioural case. JAMA 1982; 247: 2258-2260
13. Taylor KM: Decision difficult: breast cancer physicians [doctoral thesis], McGiII University, Montreal, 1986
14. Taylor KM, Feldstein M, Skeel R et al: Fundamental dilemmas with physician participation in randomized clinical trials. J Clin Oncol 1994; 12: 1796-1806
15. Chapman M: Canadian experience with predictive testing for Huntington disease: lessons for genetic testing and policy makers. Am J Hum Genet 1992; 42: 508-515
16. Pelias MZ: Duty to disclose in medical genetics: a legal perspective. Am J Med Genet 1991; 39: 347-354
17. Geller G, Tambor ES, Bernhardt BA et al: Physicians' attitudes toward disclosure of genetic information to third parties. J Law Med Ethics 1993; 21: 238-240
18. Moore AH: Genetics: the money rush is on. Fortune 1994; May 30: 94-108
19. Lerman C, Daly M, Masny A et al: Attitudes about genetic testing for breast-ovarian cancer susceptibility. J Clin Oncol 1994; 12: 843-850
20. Lerman C: Communication between patients with breast cancer and health care providers: determinants and implications. Cancer 1993; 72: 2612-2620
21. Cohen M: Designer genes. GQ Magazine 1993; Oct: 268-274
22. Kahn P: Genetic diversity project tries again. Science 1994; 266: 720-722
23. Taylor KM: Telling bad news: physician disclosure of undesirable information. Social Health Illn 1988; 10 (2): 109-131